Bio/Healthcare Ventures 2017

Product Code No:
Issued In:
#of Pages:
Publication Cycle:

Buy this research

150,000 yen ($1,372.50)(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 109.29 yen , 2020/01/27 Japan)

Coverage: (Product/service)

Bio/Healthcare Ventures (industry-university collaboration, bio/healthcare industrial clusters included) bio/healthcare venture capital/fund

Research Target:

Bio healthcare ventures (derived from pharmaceutical companies, medical equipment companies, university-originated ventures), METI, MEXT, and the Ministry of Health, Labour and Welfare

Research Content:

I   Current Status and Perspectives of Bio/Healthcare Ventures

  1. Recent Trends regarding Bio/Healthcare Ventures
  1. Changes in roles of bio-healthcare ventures in the life science industry
  2. Challenges toward development of life science industry
  3. Trend of ventures from universities
  4. Bio/healthcare ventures from aspect of pharmaceutical companies
  5. Business expansion in the realm of bio-healthcare ventures
  1. Establishment and Operation of Bio/Healthcare Ventures
  1. Patterns of education and generation
  2. Fundraising
  3. Securing man power
  4. Patent strategies
  5. Business alignment
  6. Initial Public Offering
  7. Exit strategy
  1. Market Environment surrounding Life Science Industry and Ventures
  1. National Policies regarding life science
  1. Bio Business Strategies at Bio/Healthcare Market Players
  1. Bio business strategies at pharmaceutical companies
  2. Bio business strategies at medical device related (tests, diagnosis, treatment) companies
  1. Governmental Support (Subsidies, Promotions) to Ventures
  2. Status of "Approved TLOs"
  3. Status of Industry-University Collaboration
  4. Status of University-Originated Ventures
  5. Status of Bio/Healthcare Industrial Clusters
  6. Bio/Healthcare Venture Market Structure

II   Business Status of Bio/Healthcare Ventures (Analysis from Questionnaire)

  1. Survey Overview
  2. Attributes of Responded Companies
  3. Business Category, Details
  4. Target Diseases
  5. Development Status by Stage
  6. Status of Intellectual Properties
  7. Exit Strategy
  8. Support Status from External Institutions
  9. Changes in Business Environment
  10. In-house Challenges
  11. Noteworthy Enterprises
  12. Entire Industry in the Future

III   Business Strategies by Bio/Healthcare Ventures

12 Ventures

IV   List of 686 Bio/Healthcare Ventures


Buy this research

written in Japanese
150,000 yen ($1,372.50)(excluding consumption tax)
* Equivalent value in US$ (Today's rate : $1= 109.29 yen , 2020/01/27 Japan)